ONCORESPONSE

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 17 Jan 2023

Owner Info

OncoResponse, Inc.

1124 Columbia Street, Suite 300

Seattle WA 98104, UNITED STATES OF AMERICA

Serial Number

2312074 filed on 6 Oct 2022

Correspondent

Tiffany D. Gehrke Marshall, Gerstein & Borun LLP

233 South Wacker Drive,,

Suite 6300,

UNITED STATES OF AMERICA

ONCORESPONSE

Classification Information

2312074

6 Oct 2022

6 Oct 2032

WORD

7 Apr 2022

Status Date	Action Taken
17^th Jan 2023	International Registration in Australia Protected correspondence sent
16^th Jan 2023	IP Right Registration Published
16^th Jan 2023	Status change to Registered/Protected
10^th Nov 2022	Application Accepted correspondence sent
9^th Nov 2022	IP Right has been Examined
9^th Nov 2022	IP Right Acceptance Published
9^th Nov 2022	Status change to Accepted
4^th Nov 2022	Awaiting examination
4^th Nov 2022	Examination expedited
3^rd Nov 2022	IP Right Filed Published